Hepatitis C Combination Therapy - Anadys Pharmaceuticals to Present at the 24th Annual JP Morgan ...

Anadys Pharmaceuticals to Present at the 24th Annual JP Morgan ...
PharmaLive.com (press release), PA - Jan 5, 2006... chemistry. Anadys' clinical development programs include ANA975 for the treatment of HCV and HBV, and ANA380 for the treatment of HBV. ...

Romark Laboratories to Develop Alinia as New Treatment for Chronic ...
EndoNurse, AZ - Jan 10, 2006... The patients were infected with HCV genotype 4. Approximately 10 percent of the patients had previously failed pegylated interferon and ribavirin combination ...

Medivir: Candidate Drug Designated within the Tibotec ...
PharmaLive.com (press release), PA - Dec 29, 2005STOCKHOLM, Sweden--(BUSINESS WIRE)--Dec 29, 2005 - The Hepatitis C Virus (HCV) collaboration with Tibotec Pharmaceuticals Ltd has recently designated a ...

Tatas to set up HCV plant in W Bengal
Sify, India - Dec 29, 2005Kolkata: Leading automobile manufacturer Tata Motors Limited has shortlisted West Bengal as the possible location for setting up a greenfield truck ...

Interferon with Ribavirin is safe and effective for children with ...
Xagena.it, Italy - Jan 1, 2006Nearly half of 118 children with chronic Hepatitis C virus ( HCV ) treated with a combination of Interferon-alpha-2b ( Intron A ) and an optimized dose of ...